全部商品分类
1/3
品牌： BD Pharmingen
下载产品说明书 下载SDS
用小程序，查商品更便捷
收藏
对比
咨询反应种属：
Human (QC Testing)
实验应用：
ELISA (Routinely Tested)
产品介绍
产品介绍
产品信息
抗原名称
IFN-γ
克隆号
(RUO)
BD化合物表
- 描述数量/尺寸零件号EntrezGene ID
- Capture Antibody Purified Anti-Human IFN-γN/A51-26131E3458
- Detection Antibody Biotin Anti-Human IFN-γN/A51-26132E3458
- Recombinant Human IFN-γ Lyophilized StandardN/A51-26136E3458
- Streptavidin-horseradish peroxidase conjugate (SAv-HRP)N/A51-9002208N/A
应用
实验应用
ELISA (Routinely Tested)
反应种属
Human (QC Testing)
目标/特异性
IFN-γ
文献
文献
研发参考(6)
1. Salih HR, Kosowski SG, Haluska VF, et al. Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells.. J Immunol. 2000; 165(5):2903-2910. (Biology).
2. Salih HR, et al. Constitutive Expression of Functional 4-1 BB (CD 137) Ligand on Carcinoma Cells. J Immunol. 2000; 165(5):2903–2910. (Biology).
3. Sester U, Sester M, Hauk M, Kaul H, Köhler H, Girndt M. T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients.. Nephrol Dial Transplant. 2000; 15(8):1217-1223. (Biology).
4. Sester U, et al. T-cell Activation Follows Th1 Rather than Th2 Pattern in Haemodialysis Patients. Nephrology Dialysis Transplantation. 2000; 15:1217–1223. (Biology).
5. Wolfers J, Lozier A, Raposo G, et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.. Nat Med. 2001; 7(3):297-303. (Biology).
6. Wolfers J, et al. Tumor-Derived Exosomes are a Source of Shared Tumor Rejection Antigens for CTL Cross-Priming. Nature Medicine. 2001; 9(3):297-303. (Biology).
参考图片
This standard curve is for demonstration only. A standard curve must be run with each assay. Typical Standard Curve and 20-plate yield were obtained in the BD Biosciences Pharmingen laboratory, using the recommended procedure and manual plate washing.
声明 ：本官网所有报价均为常温或者蓝冰运输价格，如有产品需要干冰运输，需另外加收干冰运输费。